Company Filing History:
Years Active: 2004
Title: The Innovations of Peter Licht
Introduction
Peter Licht is a notable inventor based in Bubenreuth, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for side effects associated with GnRHa therapy. His work has the potential to improve the quality of life for many patients undergoing such treatments.
Latest Patents
Peter Licht holds a patent for pharmaceutical preparations aimed at treating side effects during and/or after GnRHa therapy. This patent addresses issues such as hot flashes, prostate enlargement, and gynecomastia. The preparations contain effective amounts of chemically modified derivatives of 17α-estradiol, 17β-estradiol, and estriol. Notably, the pharmaceutical preparations featuring 14α, 15α-methylene-1,3,5(10),8-tetraene-3,17α-diol are particularly preferred.
Career Highlights
Peter Licht is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical innovations. His expertise in the field has led to the development of effective treatments that address significant medical challenges.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues such as Michael Oettel and Ludwig Wildt. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Peter Licht's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care. His patent for treating side effects during GnRHa therapy highlights the importance of research and development in the medical field.